Andrew R. Bateman

Colchester, ENG, GB 
Colchester, ENG, GB 

Overview

Andrew Bateman practices practicing medicine in Colchester, United Kingdom.

His clinical expertise encompasses Esophageal Cancer, Stroke, Memory Loss, and Dementia.

He is actively involved in clinical research, co-authoring 67 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Colchester, ENG, United Kingdom
Other Locations
Southampton, ENG SO166YD, United Kingdom
United Kingdom
Ely, ENG, United Kingdom
Cambridge, ENG, United Kingdom
Saint Ives, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Prospective, Multicenter, Randomized, Controlled Study Evaluating SIR-Spheres Y-90 Resin Microspheres Preceding Cisplatin-gemcitabine (CIS-GEM) Chemotherapy Versus CIS-GEM Chemotherapy Alone as First-line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma
Prospective, Multicenter, Randomized, Controlled Study Evaluating SIR-Spheres Y-90 Resin Microspheres Preceding Cisplatin-gemcitabine (CIS-GEM) Chemotherapy Versus CIS-GEM Chemotherapy Alone as First-line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma
Enrollment Status: Terminated
Publish Date: May 09, 2025
Intervention Type: Device, Drug
Study Drug: Cisplatin-Gemcitabine
Study Phase: Phase 2/Phase 3
Neo-AEGIS (NEOadjuvant Trial in Adenocarcinoma of the oEsophagus and oesophagoGastric Junction International Study): Randomised Clinical Trial of Neoadjuvant and Adjuvant Chemotherapy (Modified MAGIC or FLOT Regimen) vs. Neoadjuvant Chemoradiation (CROSS Protocol) in Adenocarcinoma of the Oesophagus and Oesophago-gastric Junction
Neo-AEGIS (NEOadjuvant Trial in Adenocarcinoma of the oEsophagus and oesophagoGastric Junction International Study): Randomised Clinical Trial of Neoadjuvant and Adjuvant Chemotherapy (Modified MAGIC or FLOT Regimen) vs. Neoadjuvant Chemoradiation (CROSS Protocol) in Adenocarcinoma of the Oesophagus and Oesophago-gastric Junction
Enrollment Status: Completed
Publish Date: September 30, 2022
Intervention Type: Radiation, Drug
Study Drugs: Epirubicin, Cisplatin / Oxaliplatin, 5 Flourouracil/ Capecitabine, Paclitaxel, Carboplatin, Docetaxel, Oxaliplatin, Leucovorin, 5-Fluorouracil
Study Phase: Phase 3
A Phase III Clinical Trial Evaluating TheraSphere® in Patients With Metastatic Colorectal Carcinoma of the Liver Who Have Failed First Line Chemotherapy
A Phase III Clinical Trial Evaluating TheraSphere® in Patients With Metastatic Colorectal Carcinoma of the Liver Who Have Failed First Line Chemotherapy
Enrollment Status: Completed
Publish Date: March 29, 2022
Intervention Type: Device
Study Phase: Not Applicable
View 2 Less Clinical Trials

67 Total Publications

Sustained use of compensatory technology following brain injury: experiences from Neumind users.
Sustained use of compensatory technology following brain injury: experiences from Neumind users.
Journal: Disability and rehabilitation. Assistive technology
Published: February 26, 2026

Frequently Asked Questions about Andrew R. Bateman

Is Andrew R. Bateman a top-rated expert for Esophageal Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Andrew R. Bateman is classified as an Experienced expert for Esophageal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Andrew R. Bateman participate in research or clinical trials?

Yes. Andrew R. Bateman has published 67 articles and abstracts on conditions like Esophageal Cancer. You can view a list of Andrew R. Bateman's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Bateman's expertise for a condition
ConditionClose
        View All 8 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile